OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2021-12-31-accounts

REGISTERED CHARITY NUMBER: CIO 1156435

REPORT OF THE TRUSTEES AND

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021

FOR

INTERNATIONAL MENOPAUSE SOCIETY

Haines Watts Chartered Accountants Old Station House Station Approach Newport Street Swindon Wiltshire SN1 3DU

INTERNATIONAL MENOPAUSE SOCIETY

CONTENTS OF THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021

Page
Report of the Trustees 1 to 10
Independent Examiner's Report 11
Statement of Financial Activities 12
Statement of Financial Position 13
Notes to the Financial Statements 14 to 22

INTERNATIONAL MENOPAUSE SOCIETY

REPORT OF THE TRUSTEES

FOR THE YEAR ENDED 31 DECEMBER 2021

The Trustees present their report with the financial statements of the charity for the year ended 31 December 2021. The Trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2020).

The International Menopause Society (IMS) has been registered as a Charitable Incorporated Organisation (CIO) with The Charity Commission of England and Wales since 28th March 2014. The organisation is governed by its Constitution and Rules. The Board of Directors of the charity are its Trustees for the purposes of charity law and throughout this report are collectively referred to as Trustees.

The IMS was founded in 1978 and aims to promote education, study, and research into midlife women's health. It organises, prepares, and contributes to international meetings and congresses on menopause and climacteric, and encourages the interchange of research and experience between individual members. Membership of the IMS is open to individual physicians with an interest in menopause, Scientists and other health professionals involved in basic research or clinical work in the menopause field or an interest in other aspects in the field of menopause management.

The Trustees present their annual report together with the audited financial statements of the organisation for the year ended 31 December 2021. The Trustees confirm that the Annual report and financial statements of the company comply with the current statutory requirements, the requirements of the company's governing documents and the provisions of the Charities Statement of Recommended Practice (SORP) FRS102.

OBJECTIVES AND ACTIVITIES

MISSION AND VISION

The principal object of the organisation as set out in its Constitution is: the relief of sickness and the preservation and protection of good health by the promotion and co-ordination of information, education and scientific studies of the health and well-being of peri- and post-menopausal women during and after mid-life. This object is encapsulated within the IMS Mission and Vision Statements, which were updated in December 2019.

The MISSION of IMS is to work globally to promote and support access to best practice health care for women through their menopause transition and post-reproductive years, enabling them to achieve optimal health and well-being.

The VISION of the IMS is that all women across the world will have easy and equitable access to evidencebased knowledge and health care, empowering them to make fully informed mid-life health choices.

Page 1 of 22

INTERNATIONAL MENOPAUSE SOCIETY

REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2021

OBJECTIVES AND ACTIVITIES

Significant activities

The IMS plans and reviews its strategic objectives and activities via an annual business planning cycle. The organisation's primary objectives to deliver its mission and vision include:

Public benefit

All our activities focus on supporting the awareness of menopause and the education of health professionals, so they can offer better understanding and treatment of the condition. These activities are undertaken to further our charitable purposes for the public benefit. We review our activities each year and monitor the impact of our work to ensure that we continue to fulfil our purpose of helping raise the standards of treatment of health for women in midlife. We consider how planned activities will contribute to the aims and objectives we have set.

ACTIVITIES

All IMS activities focus on supporting the awareness of menopause and the education of health professionals, so they can offer better understanding and treatment of the condition. These activities are undertaken to further our charitable purposes for the public benefit. We review our activities each year and monitor the impact of our work to ensure that we continue to fulfil our purpose of helping raise the standards of treatment of health for women in midlife. We consider how planned activities will contribute to the aims and objectives we have set.

Page 2 of 22

INTERNATIONAL MENOPAUSE SOCIETY

REPORT OF THE TRUSTEES

FOR THE YEAR ENDED 31 DECEMBER 2021

ACTIVITIES IN 2021

World Congress on Menopause

The IMS holds a World Congress on Menopause every two years to bring together the world's leading experts on menopause to present the latest science and innovation in the field of midlife women's health. The Scientific Committee for the 18[th] World Congress in 2022, to be held in Lisbon, Portugal has worked in this year to develop the scientific programme. A local organising committee was selected to develop sessions in local languages and to promote the Congress in their region. Monthly meetings of both committees have been held during 2021.

Educational Activities and Resources

IMPART

The International Menopause Society Professional Activity for Refresher Training (IMPART) is the first educational initiative pertaining to menopause that is internationally applicable to health care professionals working in, or with a special interest in, midlife women's health. It is aligned with the International Menopause Society's (IMS) mission to work globally to promote and support access to best practice health care for women through their menopause transition and post-reproductive years, enabling them to achieve optimal health and well-being. The course was developed in June 2017 and hosted on a learning platform by the organisation that was originally contracted to create it. In March 2020, the Trustees decided to take the management and further development of this course in-house and to move the course to a new learning platform.

In July 2020, the Level 1 course was updated and launched on the new platform. Since re-launch of IMPART in July 2020, over 7,000 health care professionals from around the world have registered. It has been translated into Spanish, Portuguese, Chinese, Vietnamese and Arabic. Levels 1 and 2 are available. Certificates of completion are provided for both levels, one-year free Limited Professional Membership to the IMS is awarded with completion of Level 1.

Online Education

The Trustees agreed develop online educational resources, including webinars, sponsored symposia and interviews. The purpose of these resources was to bring the world's leading experts on midlife women's health into homes and workplaces to present the latest science. Eleven webinars, two industry sponsored symposia and eighteen interviews were delivered in 2021. All of these resources are a great success, with hundreds of people from all over the world engaging with them each month. They are listed on the following pages.

Page 3 of 22

INTERNATIONAL MENOPAUSE SOCIETY

REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2021

Webinars and Symposia 2021

Page 4 of 22

INTERNATIONAL MENOPAUSE SOCIETY

REPORT OF THE TRUSTEES

FOR THE YEAR ENDED 31 DECEMBER 2021

Interviews

DATE AUDIENCE TITLE
June 2021 Women When your periods leave too early
Professor Nick Panay
June 2021 Professional Premature Ovarian Insufficiency
Professor Nick Panay
June 2021 Women The menopausal blues
Professor Pauline Maki
June 2021 Professional Identifying and treating
perimenopausal depression
Professor Pauline Maki
June 2021 Women Migraine headaches
Professor Rossella Nappi
June 2021 Professional Migraine headaches
Professor Rossella Nappi
July 2021 Women Is testosterone the answer to low
libido?
Professor Susan Davis
July 2021 Professional Testosterone and women
Professor Susan Davis
August 2021 Women Menopause more than hot flashes
Dr Louise Newson
August 2021 Professional Menopause and cardiovascular
disease
Dr Louise Newson
September 2021 Women Bone health and premature ovarian
insufficiency Professor Amanda
Vincent
September 2021 Professional Osteoporosis and POI
Professor Amanda Vincent
October 2021 Women Women and Covid: Not Quite the
Same as Men
Dr Vivien Brown
October
2021		 Professional Women and Covid: Not Quite the
Same as Men
Dr Vivien Brown
November
2021		 Women Bone health Dr Tobie
de Villiers
November 2021 Professional Osteoporosis prevention and
treatment Dr Tobie
de Villiers
December 2021 Women Bone health what why and how
Professor Steven Goldstein
December
2021		 Professional Bone health the role of muscle
Professor Steven Goldstein

Page 5 of 22

INTERNATIONAL MENOPAUSE SOCIETY

REPORT OF THE TRUSTEES

FOR THE YEAR ENDED 31 DECEMBER 2021

World Menopause Day

World Menopause Day is held every year on the 18th of October. The day was designated by the International Menopause Society (IMS) and the World Health Organisation (WHO) to raise awareness of the menopause and to support options to improve health and well-being for women in mid-life and beyond. Every year, the IMS selects a theme and publishes a White Paper, and leaflets and posters for consumers. Organisations, professionals and women are all encouraged to participate in this global awareness raising campaign by sharing our educational resources, organising events and engaging with social media posts.

The theme of World Menopause Day 2021 was Bone Health. The resources were translated into ten languages. The White Paper was published online and in print in the IMS journal, Climacteric.

Climacteric

Climacteric is the official journal of the International Menopause Society (IMS). As an international peerreviewed journal, it publishes original research and reviews of all aspects of aging in women. Climacteric was founded by the IMS in 1998 and today has become a leading journal in the publication of peer-reviewed papers on the menopause, climacteric and mid-life health. Topics covered include endocrine changes, symptoms attributed to the menopause and their treatment, hormone replacement and alternative therapies, lifestyles, and the counselling and education of peri- and postmenopausal women. Climacteric, published bimonthly, also features regular invited reviews, editorials and commentaries on recent developments.

The editorial review board of Climacteric includes leading scientific and clinical experts in the field of midlife medicine and research and is headed by its Editor-in-Chief, Professor Rod Baber of Australia. He and his team of Associate Editors act independently to set a clear editorial policy, co-ordinate peer review, and ensure a rapid response to submitted papers. At the end of 2020, the Impact Factor of the journal was 3.024.

Online Engagement

A new website was launched in 2021. It has streamlined the membership application process, enhanced accessibility of educational resources and actively engaged IMS members. Regular engagement with members continued successfully throughout 2021 via the monthly editions of Menopause Live, a scientific review of publications, and Our Menopause World, the newsletter.

FINANCIAL REVIEW

Financial position

The Trustees have a reasonable expectation that the charity has adequate resources to continue in operation for the foreseeable future. The organisation has achieved an in-year surplus of £324,208, which was due to a concerted effort to increase the number of unrestricted educational grants from the pharmaceutical industry. The total funds carried forward for the year is £1,619,246 of which £0 are restricted funds.

Page 6 of 22

INTERNATIONAL MENOPAUSE SOCIETY

REPORT OF THE TRUSTEES

FOR THE YEAR ENDED 31 DECEMBER 2021

Reserves policy

The Society has a reserves policy whereby the organisation seeks to hold reserves sufficient to meet one year's operating costs during a period of difficulty. The aim is to increase the reserves overtime to meet more than one year's operating costs to ensure we have sufficient to run the Society in the event that a World Congress, our main source of income, is ever disrupted, and to help sponsor more research in the future. The finance subcommittee of Trustees reviews the reserves policy on an annual basis. At the year-end free reserves (unrestricted funds less designated funds and functional fixed assets) amounted to £1,618,273 (2020 £1,294,185).

FUTURE PLANS

The IMS Strategic Plan for 2020-2021 sets out the following strategic goals for the organisation:

  1. Knowledge and Education: Broaden the reach and increase the impact of IMS by enhancing current activities and developing new initiatives.

  2. Membership and Stakeholders: Build and maintain a diverse and active membership, and productive partnerships with stakeholders.

3. Finances: Diversify

income streams and optimise operational costs to sustain and grow the organisation.

  1. Governance: Maintain robust operational policies and procedures to ensure consistency, quality, accountability, transparency and corporate memory.

STRUCTURE, GOVERNANCE AND MANAGEMENT

Governing document

IMS legal seat and charitable registration has been in England and Wales when accepted by the Charity Commissions as a Charitable Incorporated Organisation (CIO) on 28th March 2014, with a registered charity number of 1156435.

IMS has two governing documents - the IMS Constitution and the Rules.

The Constitution can only be amended by resolution agreed in writing by all members of IMS and then by a resolution passed by a 75% majority of votes cast at a general meeting of the members of IMS.

The Rules are designed to provide practical guidance for the day-to-day management of the Society, and can be changed by full IMS Board approval, with subsequent notification to the Charity Commission.

In the event of the charity being wound up, no member would be liable to contribute towards the organisation's costs or payment of debts or liabilities.

Page 7 of 22

INTERNATIONAL MENOPAUSE SOCIETY

REPORT OF THE TRUSTEES

FOR THE YEAR ENDED 31 DECEMBER 2021

Organisational structure

Board of Directors

The oversight of the organisation's assets and strategic direction is the responsibility of its Trustees who are elected to the Board of Directors by the members of the Society. The Trustees serve a two-year term and may seek re-election for up to two additional terms. The Trustees elect a President, General Secretary and Treasurer who, along with the chairman of CAMS and the past President, form the Executive Committee of the Board. The Trustees have complied with their duty outlined in section 4 of the Charities Act 2006 to have due regard to public benefit guidance issued by The Charity Commission. All Trustees engage in an induction programme that involves Trustee training on the organisation's work. This is coordinated by the President and the Chief Executive Officer (CEO). Continued training and development is regularly reviewed and offered to the Trustees as needs are identified.

Secretariat

The CEO is responsible for the strategic management and day to day running of the organisation. Pay and remuneration strategy is headed by the Treasurer with support from the Officers and discussed and agreed annually.

Risk management

As part of the periodical strategic review the Trustees identify major risks to the Society and takes steps to mitigate the identified risks. The Board of Trustees have an ongoing brief to review all risks and assess them on a regular basis to ensure that their financial or ethical impact have been identified and monitored. All financial impacts are reviewed regularly by the Finance subcommittee headed by the Treasurer and the IMS reserves policy provides contingency cover should any risk materialise. Although we are only required by the Charity Commission to run the Society for one year, we have enough reserves to cover a much longer period in case a World Congress should fail completely. The current ethical code for the organisation is available on the IMS website and a new Ethical standards subcommittee for the Board has started to review the current code and make recommendations for future improvements in our Code of Practice documents e.g. Disclosure of Conflicts statement. The Society does not anticipate any factors likely to affect future performance, unless a world congress is cancelled or disrupted in any way, which might affect the incomes to support the charity's activities. However, our reserves are designed to cover running costs to ameliorate this potential factor and insurance is in place to recuperate any potential losses from a World Congress.

Page 8 of 22

INTERNATIONAL MENOPAUSE SOCIETY

REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2021

REFERENCE AND ADMINISTRATIVE DETAILS Registered Charity number

CIO 1156435

Principal address 13 Leechwell Street Totnes Devon TQ9 5SX

Board of Trustees 2021

Professor Steven Goldstein (USA) President Professor Rosella Nappi (IT) General Secretary Dr Ang Seng Bin (SG) Treasurer Mr Nicholas Panay (UK) President elect Professor Pauline Maki (USA) Dr Sonia Cerdas (CR) Professor Robert Langer (USA) Professor Sunila Khandelwal (IN) Mr Tim Hillard (UK) Professor Xiangyan Ruan (CH) Professor Amanda Vincent (AU) Professor Amos Pines (IL) Dr Marla Shapiro (CAN) Professor Santiago Palacios (ESP) Professor Susan Davis (AU) Immediate Past President Professor Tommaso Simoncini (IT) Chairman, Council of Affiliated Menopause Societies

Chief Executive Officer (CEO) Rebecca Cheshire

Page 9 of 22

INTERNATIONAL MENOPAUSE SOCIETY

REPORT OF THE TRUSTEES

FOR THE YEAR ENDED 31 DECEMBER 2021

Independent Examiner Haines Watts Chartered Accountants Old Station House Station Approach Newport Street Swindon Wiltshire SN1 3DU

Approved by order of the board of trustees on 29[th] October 2022 and signed on its behalf by:

Professor Steven R. Goldstein Trustee and President, IMS 2021

Page 10 of 22

INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF INTERNATIONAL MENOPAUSE SOCIETY

Independent examiner's report to the trustees of International Menopause Society

I report to the charity trustees on my examination of the accounts of International Menopause Society (the Trust) for the year ended 31 December 2021.

Responsibilities and basis of report

As the charity trustees of the Trust you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 ('the Act').

I report in respect of my examination of the Trust's accounts carried out under section 145 of the Act and in carrying out my examination I have followed all applicable Directions given by the Charity Commission under section 145(5)(b) of the Act.

Independent examiner's statement

Since your charity's gross income exceeded £250,000 your examiner must be a member of a listed body. I can confirm that I am qualified to undertake the examination because I am a registered member of ACA which is one of the listed bodies.

I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:

  1. accounting records were not kept in respect of the Trust as required by section 130 of the Act; or

  2. the accounts do not accord with those records; or

  3. the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination.

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

Susan Plumb ACA Haines Watts Chartered Accountants Old Station House Station Approach Newport Street Swindon Wiltshire SN1 3DU

Date: 31 Oct 2022

Page 11 of 22

INTERNATIONAL MENOPAUSE SOCIETY

STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 DECEMBER 2021

Notes
INCOME AND ENDOWMENTS FROM
Donations and legacies
2
Investment income
3
Total
EXPENDITURE ON
Charitable activities
World Congress
Support costs
IMPART Program
Androgen Task Force
Webinars
Total
Net gains on investments
NET INCOME/(EXPENDITURE)
RECONCILIATION OF FUNDS
Total funds brought forward
TOTAL FUNDS CARRIED FORWARD		 Unrestricted
funds
£
454,711
40,910
495,621
428
174,691
28,612
-
37,162
240,893
75,690
330,418
1,288,828
1,619,246
Restricted
funds
£
-
-
-
-
6,210
-
-
-
6,210
-
(6,210)
6,210
-		 2021

Total
funds
£
454,711
40,910
495,621
428
180,901
28,612
-
37,162
247,103
75,690
324,208
1,295,038
1,619,246		 2020
Total
funds
£
240,824
39,199
280,023
252,611
178,133
3,965
211
8,038
442,958
36,657
(126,278)
1,421,316
1,295,038

Page 12 of 22

INTERNATIONAL MENOPAUSE SOCIETY

STATEMENT OF FINANCIAL POSITION

31 DECEMBER 2021

Notes
FIXED ASSETS
Tangible assets
7
Investments
8
CURRENT ASSETS
Debtors
9
Cash at bank
CREDITORS
Amounts falling due within one year
10
NET CURRENT ASSETS
TOTAL ASSETS LESS CURRENT LIABILITIES
NET ASSETS
FUNDS
11
Unrestricted funds
Restricted funds
TOTAL FUNDS		 Unrestricted
funds
£
973
1,211,402
1,212,375
90,690
351,095
441,785
(34,914)
406,871
1,619,246
1,619,246
Restricted
funds
£
-
-
-
-
-
-
-
-
-
-		 2021

Total
funds
£
973
1,211,402
1,212,375
90,690
351,095
441,785
(34,914)
406,871
1,619,246
1,619,246
1,619,246
-
1,619,246		 2020
Total
funds
£
853
1,095,670
1,096,523
85,045
221,053
306,098
(107,583)
198,515
1,295,038
1,295,038
1,288,828
6,210
1,295,038

The financial statements were approved by the Board of Trustees and authorised for issue on 29[th] October and were signed on its behalf by:

Professor Steven R Goldstein Trustee and President, IMS 2020

Page 13 of 22

INTERNATIONAL MENOPAUSE SOCIETY

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2021

1. ACCOUNTING POLICIES

Basis of preparing the financial statements

The financial statements of the charity, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Charities Act 2011. The financial statements have been prepared under the historical cost convention, with the exception of investments which are included at market value, as modified by the revaluation of certain assets.

The financial statements are prepared in sterling, which is the functional currency of the entity and rounded to the nearest £.

Income

All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.

Expenditure

Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Computer equipment 25% straight line

Taxation

The charity is exempt from tax on its charitable activities.

Fund accounting

Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.

Page 14 of 22

INTERNATIONAL MENOPAUSE SOCIETY

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 31 DECEMBER 2021

1. ACCOUNTING POLICIES - continued

Fund accounting

Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.

Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.

Foreign currencies

Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the statement of financial position date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Pension costs and other post-retirement benefits

The charity operates a defined contribution pension scheme. Contributions payable to the charity's pension scheme are charged to the Statement of Financial Activities in the period to which they relate.

Investments

Listed investments are measured at fair value with changes in fair value being recognised in income or expenditure.

Debtors and prepayments

Trade and other debtors are recognised at the settlement amount due after any trade discounts. Prepayments are valued at the amount prepaid net of any discounts.

Creditors and provisions

Creditors and provisions are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount to settle the obligation can be measured or estimated reliably.

Page 15 of 22

INTERNATIONAL MENOPAUSE SOCIETY

NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 DECEMBER 2021

2. DONATIONS AND LEGACIES

Regional meetings
Membership
Educational grants
3.
INVESTMENT INCOME
Income from listed investments		 2021
£
50,000
93,720
310,991
454,711
2021
£
40,910		 2020
£
50,000
37,381
153,443
240,824
2020
£
39,199

4. TRUSTEES' REMUNERATION AND BENEFITS

There were no trustees' remuneration or other benefits for the year ended 31 December 2021 nor for the year ended 31 December 2020.

Trustees' expenses

The total amount of travel expenses reimbursed to 0 trustees (2020 2 trustees) during the year was £0 (2020 £1,616).

5. STAFF COSTS

Wages and salaries
Social security costs
Other pension costs		 2021
£
108,722
2,878
1,673
113,273		 2020
£
85,939
9,327
922
96,188

The average monthly number of employees during the year was as follows:

2021 2020
Administrative 3 2

One employee received emoluments in excess of £60,000.

Key Management Personnel

Key management personnel include all persons that have authority and responsibility for planning, directing and controlling the activities of the charity. The total compensation paid to key management personnel for services provided to the charity was £85,435 (2020: £78,562).

Page 16 of 22

INTERNATIONAL MENOPAUSE SOCIETY

NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 DECEMBER 2021

6.
COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES
Unrestricted
funds
£
INCOME AND ENDOWMENTS FROM
Donations and legacies
240,824
Investment income
39,199
Total
280,023
EXPENDITURE ON
Charitable activities
World Congress
252,611
Support costs
190,136
Androgen Task Force
-
Total
442,747
Net gains on investments
36,657
NET INCOME/(EXPENDITURE)
(126,067)
RECONCILIATION OF FUNDS
Total funds brought forward
1,414,895
TOTAL FUNDS CARRIED FORWARD
1,288,828
Restricted
funds
£
-
-
-
-
-
211
211
-
(211)
6,421
6,210
Total
funds
£
240,824
39,199
280,023
252,611
190,136
211
442,958
36,657
(126,278)
1,421,316
1,295,038

Page 17 of 22

INTERNATIONAL MENOPAUSE SOCIETY

NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 DECEMBER 2021

7. TANGIBLE FIXED ASSETS

Fixtures
and
Computer
fittings
equipment
£
£
COST
At 1 January 2021
-
1,969
Additions
362
-
At 31 December 2021
362
1,969
DEPRECIATION
At 1 January 2021
-
1,116
Charge for year
72
170
At 31 December 2021
72
1,286
NET BOOK VALUE
At 31 December 2021
290
683
At 31 December 2020
-
853
8.
FIXED ASSET INVESTMENTS
MARKET VALUE
At 1 January 2021 and
31 December 2021
PROVISIONS
Revaluation adjustments
NET BOOK VALUE
At 31 December 2021
At 31 December 2020
Totals
£
1,969
362
2,331
1,116
242
1,358
973
853
Listed
investments
£
1,095,670
(115,732)
1,211,402
1,095,670

At the year-end investments represent unit trusts held by Schroders.

Page 18 of 22

continued...

INTERNATIONAL MENOPAUSE SOCIETY

NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 DECEMBER 2021

9. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

9.
DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
Trade debtors
Prepayments and accrued income
10.
CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
Taxation and social security
Other creditors		 2021
£
29,253
61,437
90,690
2021
£
3,325
31,589
34,914		 2020
£
57,200
27,845
85,045
2020
£
2,739
104,844
107,583

Included in accruals and deferred income above is £6,715 (2020 £9,189) of deferred income relating to membership for 2022. All deferred income is released in the following year.

11. MOVEMENT IN FUNDS

Unrestricted funds
General fund
IMPART Program
IMPART Program – On-line training
Restricted funds
Androgen Task Force
TOTAL FUNDS		 At 1/1/21
£
1,279,347
9,481
-
1,288,828
6,210
1,295,038		 Net
movement

in funds
£
330,418
-
-
330,418
(6,210)
324,208		 Transfers

between

funds
£
(133,519)
(9,481)
143,000
-
-
-
At
31/12/21
£
1,476,246
(9,481)
143,000
1,619,246
-
1,619,246

Page 19 of 22

continued...

INTERNATIONAL MENOPAUSE SOCIETY

NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 DECEMBER 2021

11. MOVEMENT IN FUNDS - continued

Net movement in funds, included in the above are as follows:

Unrestricted funds
General fund
Restricted funds
Androgen Task Force
TOTAL FUNDS
Comparatives for movement in funds
Unrestricted funds
General fund
IMPART Program
Restricted funds
Androgen Task Force
TOTAL FUNDS		 Incoming
resources
£
495,621
-
495,621
At 1/1/20
£
1,414,895
-
1,414,895
6,421
1,421,316

Resources
expended
£
(240,893)
(6,210)
(247,103)
Net
movement
in funds
£
(126,067)
-
(126,067)
(211)
(126,278)


Gains and
losses
£
75,690
-
75,690
Transfers
between
funds
£
(9,481)
9,481
-
-
-
Movement
in funds
£
330,418
(6,210)
324,208

At
31/12/20
£
1,279,347
9,481
1,288,828
6,210
1,295,038

Comparative net movement in funds, included in the above are as follows:

Unrestricted funds
General fund
Restricted funds
Androgen Task Force
TOTAL FUNDS		 Incoming
resources
£
280,023
-
280,023		 Resources
expended
£
(442,747)
(211)
(442,958)		 Gains and
Movement
losses
in funds
£
£
36,657
(126,067)
-
(211)
36,657
(126,278)

Page 20 of 22

continued...

INTERNATIONAL MENOPAUSE SOCIETY

NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 DECEMBER 2021

11. MOVEMENT IN FUNDS - continued

A current year 12 months and prior year 12 months combined position is as follows:

Unrestricted funds
General fund
IMPART Program
IMPART Program – on-line training
Restricted funds
Androgen Task Force
TOTAL FUNDS		 At 1/1/20
£
1,414,895
-
1,414,895
6,421
1,421,316		 Net
movement

in funds
£
204,351
-
204,351
(6,421)
197,930		 Transfers

between

funds
£
(143,000)
-
143,000
-
-
-
At
31/12/21
£
1,476,246
-
143,000
1,619,246
-
1,619,246

A current year 12 months and prior year 12 months combined net movement in funds, included in the above are as follows:

Unrestricted funds
General fund
Restricted funds
Androgen Task Force
TOTAL FUNDS		 Incoming
resources
£
775,644
-
775,644		 Resources
expended
£
(683,640)
(6,421)
(690,061)		 Gains and
Movement
losses
in funds
£
£
112,347
204,351
-
(6,421)
112,347
197,930

Page 21 of 22

continued...

INTERNATIONAL MENOPAUSE SOCIETY

NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 DECEMBER 2021

12. RELATED PARTY DISCLOSURES

There were no related party transactions for the year ended 31 December 2021.

Page 22 of 22